Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Myeloid Leukemia ◽

Working Party ◽

Core Binding Factor ◽

Binding Factor ◽

Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Haematologica ◽

10.3324/haematol.2014.105197 ◽

2014 ◽

Vol 99 (8) ◽

pp. 1380-1386 ◽

Cited By ~ 21

Author(s):

A. Nagler ◽

M. Labopin ◽

N.-C. Gorin ◽

F. Ferrara ◽

M. A. Sanz ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Acute Leukemia ◽

Marrow Transplantation ◽

Myeloid Leukemia ◽

Working Party ◽

European Group ◽

Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Haematologica ◽

10.3324/haematol.2017.178251 ◽

2017 ◽

Vol 103 (2) ◽

pp. 256-265 ◽

Cited By ~ 6

Author(s):

Xavier Poiré ◽

Myriam Labopin ◽

Emmanuelle Polge ◽

Jakob Passweg ◽

Charles Craddock ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

Tandem Duplication ◽

Working Party ◽

Internal Tandem Duplication ◽

Flt3 Internal Tandem Duplication ◽

T‐cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3‐ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

American Journal of Hematology ◽

10.1002/ajh.25082 ◽

2018 ◽

Vol 93 (6) ◽

pp. 736-744 ◽

Cited By ~ 9

Author(s):

Jonathan Canaani ◽

Myriam Labopin ◽

Xiao‐Jun Huang ◽

William Arcese ◽

Fabio Ciceri ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Acute Leukemia ◽

European Society ◽

Myeloid Leukemia ◽

Working Party ◽

Prognostic Impact ◽

Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2017.12.776 ◽

2018 ◽

Vol 24 (4) ◽

pp. 751-757 ◽

Cited By ~ 15

Author(s):

Avichai Shimoni ◽

Myriam Labopin ◽

Bipin Savani ◽

Rose-Marie Hamladji ◽

Dietrich Beelen ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Acute Leukemia ◽

Allogeneic Stem Cell Transplantation ◽

European Society ◽

Myeloid Leukemia ◽

Working Party ◽

Faculty Opinions recommendation of Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1158379.618531 ◽

2009 ◽

Author(s):

Riccardo Varaldo

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Clinical Outcomes ◽

Myeloid Leukemia ◽

Core Binding Factor ◽

Hematopoietic Stem ◽

Binding Factor ◽

Autologous Stem Cell Transplantation with PCR-Negative Graft Would Be Associated with a Favorable Outcome in Core-Binding Factor Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2008.08.012 ◽

2008 ◽

Vol 14 (11) ◽

pp. 1262-1269 ◽

Cited By ~ 17

Author(s):

Hideki Nakasone ◽

Koji Izutsu ◽

Satoshi Wakita ◽

Hiroki Yamaguchi ◽

Michiko Muramatsu-Kida ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Myeloid Leukemia ◽

Favorable Outcome ◽

Core Binding Factor ◽

Binding Factor ◽

Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation

Haematologica ◽

10.3324/haematol.2017.168716 ◽

2017 ◽

Vol 103 (2) ◽

pp. 237-245 ◽

Cited By ~ 24

Author(s):

Christoph Schmid ◽

Liesbeth C. de Wreede ◽

Anja van Biezen ◽

Jürgen Finke ◽

Gerhard Ehninger ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Working Party ◽

Secondary Acute Myeloid Leukemia ◽

Registry Analysis ◽

Post‐transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA‐identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Cancer ◽

10.1002/cncr.33255 ◽

2020 ◽

Cited By ~ 1

Author(s):

Giorgia Battipaglia ◽

Myriam Labopin ◽

Rose‐Marie Hamladji ◽

Didier Blaise ◽

Patrice Chevallier ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Acute Leukemia ◽

Myeloid Leukemia ◽

Antithymocyte Globulin ◽

Working Party ◽

Post Transplantation ◽

Allogeneic hematopoietic stem cell transplantation improved survival for adult core binding factor acute myeloid leukemia patients with intermediate- and adverse-risk genetics in the 2017 ELN

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2020.10.010 ◽

2020 ◽

Author(s):

Tanzhen Wang ◽

Sifan Chen ◽

Jia Chen ◽

Tianhui Liu ◽

Tongtong Zhang ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Core Binding Factor ◽

Hematopoietic Stem ◽

Binding Factor ◽

Do Patients with High Risk or Relapsed Core Binding Factor Acute Myeloid Leukemia Benefit from Salvage Allogeneic Stem Cell Transplantation?

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2013.12.082 ◽

2014 ◽

Vol 20 (2) ◽

pp. S69-S70

Author(s):

Gabriela Hobbs ◽

Ashwin Kishtagari ◽

Patrick Hilden ◽

Juliet N. Barker ◽

Ann A. Jakubowski ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Myeloid Leukemia ◽

Core Binding Factor ◽

Binding Factor ◽